Director, Risk Management & Inspection Readiness

Remote

Cabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA™ platform encompasses two complementary strategies which aim to advance the discovery and development of engineered T cell therapies with the potential to become deep and durable, perhaps curative, treatments for a broad range of autoimmune diseases. The lead CARTA (Chimeric Antigen Receptor T cells for Autoimmunity) strategy is prioritizing the development of rese-cel, a 4-1BB-containing fully human CD19-CAR T cell investigational therapy. Rese-cel is currently being evaluated in the RESET™ (REstoring SElf-Tolerance) clinical development program spanning multiple therapeutic areas, including rheumatology, neurology and dermatology. Cabaletta Bio’s headquarters and labs are located in Philadelphia, PA. For more information, please visit www.cabalettabio.com and connect with us on LinkedIn.

 

Uniquely Differentiated. Rapid. Elegant.

At Cabaletta, we are driven by the shared mission of developing cures, where a patients’ own cells are used to fight disease. We are building a culture grounded in the knowledge that successful cures can be achieved for patients if every member of the Cabaletta is focused on the success of the team. To nurture this, we make an active commitment to the well-being and continuous growth of each employee who joins the team. In this way, we are not only working to improve the lives of patients, but of everyone involved. #CabalettaCrew. 

We’re proud to be a Great Place to Work-Certified™ company! #GPTWcertified Check out what our employees say makes working here so great:  Working at Cabaletta Bio Inc | Great Place to Work®

Department: Quality & Compliance

Reports to: Chief Compliance Officer

Location: Philadelphia, PA (hybrid)

Classification: Full-time, Exempt

Position Summary

Cabaletta Bio is seeking a Director, Risk Management & Inspection Readiness to lead two of the most critical, interdependent programs supporting our path to BLA submission and commercial launch. This role owns the enterprise risk management (ERM) program and the cross-functional inspection readiness program, ensuring that the company identifies, prioritizes, and mitigates risks while building demonstrable readiness for FDA pre-license and pre-approval inspections (PLI/PAI), BIMO inspections, and global health authority engagements.

The Director will serve as a strategic partner to the CCO and senior leadership, translating risk intelligence into inspection readiness priorities and translating inspection findings and gap assessments back into the enterprise risk profile. This is a high-visibility role with regular exposure to the Leadership Team, Operating Leadership Team, and Audit Committee.

Key Responsibilities

Enterprise & Quality Risk Management

  • Own and mature the enterprise risk management (ERM) program, including the annual risk assessment cycle, risk register maintenance, mitigation tracking, and reporting to executive leadership and the Audit Committee
  • Facilitate risk assessments across functions, partnering with risk owners to define risk statements, scoring, mitigation plans, and escalation paths
  • Lead quality risk management (QRM) in alignment with ICH Q9(R1), embedding risk-based decision-making into quality systems, deviation/CAPA management, change control, and supplier oversight
  • Oversee risk-based vendor and CDMO oversight, including risk profiles and escalation frameworks for external manufacturing and testing partners
  • Integrate commercial compliance risk considerations into the enterprise risk profile as the company approaches launch
  • Develop risk dashboards, heat maps, and executive reporting that drive prioritization and resourcing decisions

Inspection Readiness

  • Lead the cross-functional inspection readiness program in support of BLA submission, including program governance, roadmap execution, and monthly dashboard reporting in partnership with the PMO
  • Plan and execute the gap assessment portfolio across GMP, GCP, GLP, and quality system domains; drive risk-prioritized remediation to closure
  • Design and lead internal and external mock inspections, including inspection logistics, front room/back room operations, SME preparation, and storyboard development
  • Build inspection response infrastructure: document request workflows, escalation protocols, and real-time response management for PLI, PAI, and BIMO inspections
  • Partner with CMC, Clinical, Regulatory, Medical Affairs, and TechOps to define function-specific readiness plans, document collection strategies, and training
  • Establish readiness sign-off criteria and lead final organizational readiness verification ahead of submission and anticipated inspections

Leadership & Cross-Functional Influence

  • Present risk and readiness status to senior leadership, governance committees, and the Audit Committee; tailor messaging by audience from enterprise to product to function level
  • Build, coach, and develop a small team as the function scales; manage consultants and contract resources as needed
  • Champion a culture of risk awareness and inspection readiness as a continuous state, not a point-in-time event
  • Contribute to Quality & Compliance strategic planning, including workforce planning, budgeting, and systems roadmaps

Qualifications

Required

  • Bachelor's degree in life sciences, engineering, or related field; advanced degree preferred
  • 10+ years of progressive experience in biotech/pharmaceutical quality, compliance, or risk management, including 3+ years in a leadership role
  • Direct experience preparing for and managing FDA inspections (PAI, PLI, and/or BIMO); experience hosting inspections strongly preferred
  • Working knowledge of ICH Q9/Q10, 21 CFR Parts 210/211/600, GCP/GLP requirements, and quality risk management methodologies
  • Demonstrated success leading cross-functional programs with executive-level reporting and governance
  • Experience with CDMO/external manufacturing oversight and supplier quality risk management
  • Excellent written and verbal communication skills, including executive presentation and board-level reporting

Preferred

  • Cell and gene therapy or advanced therapy (ATMP) experience
  • Experience in a clinical-stage company transitioning to commercial (first BLA/MAA)
  • Enterprise risk management experience (COSO ERM or equivalent framework)
  • Experience with eQMS platforms and risk management tools
  • Certifications such as ASQ CQA, RAPS RAC, or PMP

Why This Role

This is a rare opportunity to build and own both the risk and readiness backbone of a first commercial launch in cell therapy — shaping how a clinical-stage company de-risks its path to patients with serious autoimmune diseases.

Our name – Cabaletta – is derived from the operatic term that represents a rapid, repetitive, and technically challenging section of an operatic aria, designed to showcase the skills of the lead singer. Analogously, Cabaletta Bio strives to achieve rapid and repetitive product development, building on our indication prioritization and biologic platform that targets the driver of specific autoimmune diseases without the need for long-term immunosuppression.

For more information, please visit  https://www.cabalettabio.com/join-our-crew

Our most important asset is our people, and we offer competitive benefits, PTO, and stock option plans.

Cabaletta Bio is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, gender identity, sexual orientation, age, religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law.

Cabaletta Bio, Inc. does not accept unsolicited resumes from recruiters, employment agencies, or staffing firms. To conduct business with Cabaletta, a Master Services Agreement (MSA) must be executed and confirmed prior to submitting any information relating to a potential candidate. Without a signed MSA, Cabaletta shall not be responsible to any individual or entity for any payment relating to any form of fee or compensation.

And, if a resume or candidate is submitted by a recruiter, an employment agency, or a staffing firm without a fully executed MSA, Cabaletta has the unrestricted right to pursue and hire any of those candidate(s) without any legal or financial responsibility to the recruiter, agency, and/or firm.

#LI-REMOTE